1980
DOI: 10.1007/bf00411276
|View full text |Cite
|
Sign up to set email alerts
|

Tumor inhibition by metallocenes: Antitumor activity of titanocene dihalides (C5H5)2TiX2 (X=F, Cl, Br, I, NCS) and their application in buffered solutions as a method for suppressing drug-induced side effects

Abstract: The antitumor activity of titanocene dihalides (C5H5)2TiX2 with X=F, Cl, Br, I, NCS is investigated against Ehrlich ascites tumor in CF 1 mice. Varying doses of the compounds are applied as single i.p. injections 24 h p.t.t. both in non-buffered (pH 1.4-3.9) and buffered (pH 4.2-5.9) solutions or suspensions, all of the substances achieving in optimum doses cure rates of 100% on day 120 p.t.t. This corresponds to I.L.S. values of 600-750% referred to the untreated controls. Some drug-induced side effects, espe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
22
0
1

Year Published

1997
1997
2016
2016

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 75 publications
(24 citation statements)
references
References 12 publications
1
22
0
1
Order By: Relevance
“…It showed an IC 50 of (1.2 AE 0.4) mm in HeLa S3 and (3.0 AE 1.3) mm in Hep G2 cells. All IC 50 values are given as mean values from at least three independent experiments each done in four replicates.…”
Section: Resultsmentioning
confidence: 99%
“…It showed an IC 50 of (1.2 AE 0.4) mm in HeLa S3 and (3.0 AE 1.3) mm in Hep G2 cells. All IC 50 values are given as mean values from at least three independent experiments each done in four replicates.…”
Section: Resultsmentioning
confidence: 99%
“…157 These involve the encapsulation of a relatively hydrophobic complex (e.g. Pd(acac) 2 ) within a hydrophobic pocket of a metal-containing host (69). These metalla-cages ( Figure 27) can release hydrophobic drugs like pyrene-R (70) efficiently following uptake into a cell.…”
Section: From Non-hydrolysable Complexes To Stable Multi-core Assembliesmentioning
confidence: 99%
“…[5,6] Further examples include {Ru(arene)} complexes, [7] several {Co(CO) 2 (alkyne)} derivatives [8][9][10][11] in addition to the well-studied titanocene dichloride which has been in clinical trials. [12][13][14][15] DNA interaction has been suggested as the mode of action, at least for some of the organometallic antitumor agents. However, the question of nuclear localization, although a prerequisite for this mode of action, has usually been taken for granted without ever being investigated in detail.…”
mentioning
confidence: 99%